AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
161.74
+5.92 (3.80%)
Oct 14, 2026, 12:24 PM EDT - Market open

AstraZeneca Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, AstraZeneca stock has a consensus rating of "Buy" and an average price target of $207.16. The average 1-year stock price forecast is 28.08% higher than the current stock price, while the lowest is $158 (-2.31%) and the highest is $240 (+48.39%).

Price Target: $207.16 (+28.08%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$158$207.16$209$240
Change-2.31%+28.08%+29.22%+48.39%

Analyst Ratings

The average analyst rating for AstraZeneca stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy776777
Buy222333
Hold112111
Sell000000
Strong Sell000001
Total101010111112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Buy
Maintains
$211
BuyMaintains$211+30.75%Oct 13, 2026
Citi
Citi
Buy
Maintains
n/a
BuyMaintainsn/an/aOct 13, 2026
Berenberg Bank
Berenberg Bank
Buy
Maintains
$198
BuyMaintains$198+22.58%Oct 7, 2026
Jefferies
Jefferies
Buy
Maintains
$231
BuyMaintains$231+43.01%Oct 7, 2026
Bernstein
Bernstein
Buy
Maintains
$267 → $262
BuyMaintains$267 → $262+61.81%Oct 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
63.19B
from 58.74B
Increased by 7.58%
Revenue Next Year
67.06B
from 63.19B
Increased by 6.13%
EPS This Year
10.22
from 9.16
Increased by 11.58%
EPS Next Year
11.39
from 10.22
Increased by 11.41%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
37.42B44.35B45.81B54.07B58.74B63.19B
Revenue Growth
40.58%18.53%3.29%18.04%8.63%7.58%
Gross Profit
25.41B35.71B37.77B44.44B47.99B52.14B
Gross Margin
67.92%80.52%82.44%82.18%81.71%82.51%
Operating Income
2.90B8.81B9.70B12.93B14.29B21.05B
Net Income
112.00M3.29B5.96B7.04B10.23B11.90B
EPS
----9.1610.22
EPS Growth
----11.57%11.58%
Forward PE
-----15.82
Dividend / Share
2.872.902.903.103.203.34
Dividend Growth
2.50%1.05%-6.90%3.23%4.44%
Free Cash Flow
----11.77B9.71B
No. Analysts
-----25
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High64.4B
Avg63.2B
Low58.5B

Revenue Growth

Revenue Growth202620272028
High
9.6%
Avg
7.6%
Low
-0.4%

EPS Forecast

EPS202620272028
High10.53
Avg10.22
Low9.64

EPS Growth

EPS Growth202620272028
High
15.0%
Avg
11.6%
Low
5.2%